| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 3 | +33.33% | -3.63% | -1.17% | -2.46% | -4.87% | — |
| 14d | 3 | +33.33% | -6.71% | -2.80% | -3.90% | -11.68% | — |
| 30d | 3 | +0.00% | -7.65% | -0.56% | -7.08% | -6.18% | — |
| 60d | 3 | +66.67% | -7.76% | -0.40% | -7.36% | +0.59% | — |
| 90d | 3 | +33.33% | -5.66% | +1.82% | -7.49% | -11.69% | — |
| 180d | 3 | +66.67% | +25.26% | +8.75% | +16.51% | +49.99% | — |
| 1y | 3 | +66.67% | +50.72% | +17.11% | +33.61% | +8.17% | — |
| 2y | 3(1 pending) | +100.00% | +64.43% | +48.07% | +16.36% | +16.36% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| CNTX CONTEXT THERAPEUTICS INC. | PURCHASEGRANT Stock grant | 275,000 | — | — | 275,000 | Feb 19, 2026 | Feb 23, 2026 ↗ | View → |
| CNTX CONTEXT THERAPEUTICS INC. | PURCHASE Chief Financial Officer | 40,010 | $0.64 | $25.5K | 80,010 | Jun 6, 2025 | Jun 10, 2025 ↗ | View → |
| CNTX CONTEXT THERAPEUTICS INC. | PURCHASEGRANT Stock grant | 371,800 | — | — | 371,800 | Feb 13, 2025 | Feb 14, 2025 ↗ | View → |
| CNTX CONTEXT THERAPEUTICS INC. | PURCHASEGRANT Stock grant | 160,115 | — | — | 160,115 | Mar 21, 2024 | Mar 22, 2024 ↗ | View → |
| CNTX CONTEXT THERAPEUTICS INC. | PURCHASEGRANT Stock grant | 158,001 | — | — | 158,001 | Feb 13, 2023 | Feb 14, 2023 ↗ | View → |
| CNTX CONTEXT THERAPEUTICS INC. | PURCHASE Chief Financial Officer | 25,000 | $0.74 | $18.5K | 40,000 | Dec 16, 2022 | Dec 19, 2022 ↗ | View → |
| CNTX CONTEXT THERAPEUTICS INC. | PURCHASE Chief Financial Officer | 15,000 | $1.80 | $27.0K | 15,000 | Aug 17, 2022 | Aug 17, 2022 ↗ | View → |
| CNTX CONTEXT THERAPEUTICS INC. | PURCHASEGRANT Stock grant | 112,470 | — | — | 112,470 | Feb 25, 2022 | Feb 25, 2022 ↗ | View → |
| CNTX CONTEXT THERAPEUTICS INC. | PURCHASEGRANT Stock grant | 52,753 | — | — | 52,753 | Nov 1, 2021 | Nov 1, 2021 ↗ | View → |